Definition And Patient Selection

  • Epilepsy surgery is an early, disease-modifying, potentially curative intervention for pediatric Drug-Resistant Epilepsy (DRE).
  • Definition of DRE (ILAE): Failure of adequate trials of two tolerated and appropriately chosen anti-seizure medication (ASM) schedules to achieve sustained seizure freedom.
  • The probability of achieving seizure freedom with a third ASM after failing two regimens is less than 4%; children meeting DRE criteria should be referred to a Comprehensive Epilepsy Care Center within 6 months.
  • Early surgery prevents the development of secondary epileptic encephalopathy and cognitive regression in the developing brain.

Pre-Surgical Evaluation

The goal of pre-surgical evaluation is to accurately delineate the Epileptogenic Zone (EZ)—the minimal area of cortex that must be resected or disconnected to achieve seizure freedom—while preserving eloquent cortex.

Phase I (Non-Invasive Evaluation)

  • High-Resolution Epilepsy Protocol MRI (3T or 7T): High spatial resolution reveals subtle structural lesions such as Focal Cortical Dysplasia (FCD Type II), hippocampal sclerosis, and low-grade developmental tumors (DNET, ganglioglioma).
  • Long-Term Video-EEG Monitoring: Records habitual ictal events to correlate electrographic onset with clinical semiology.
  • FDG-PET / MRI Fusion: Identifies interictal glucose hypometabolism in the epileptogenic zone.
  • SISCOM (Subtraction Ictal-Interictal SPECT Co-registered to MRI): Radioisotope injected at the earliest seizure onset demonstrates ictal hyperperfusion.
  • Magnetoencephalography (MEG): Measures magnetic fields generated by neuronal currents without skull distortion; maps spike sources and eloquent somatosensory cortex.

Phase II (Invasive Evaluation)

  • Stereo-Electroencephalography (SEEG): Robotic stereotactic assistance (ROSA) places multiple intracerebral depth electrodes in 3D trajectories to map complex epileptogenic networks without open craniotomy.

Surgical Classifications And Procedures

CategorySurgical ProcedureIndications And Mechanisms
ResectiveLesionectomy / LobectomyComplete microsurgical resection of well-circumscribed lesions (FCD, DNET, mesial temporal sclerosis).
DisconnectiveFunctional HemispherotomyDisconnection of an entire diseased cerebral hemisphere; preferred over anatomical hemispherectomy to avoid blood loss and superficial hemosiderosis in hemimegalencephaly, Rasmussen encephalitis, or Sturge-Weber syndrome.
DisconnectiveCorpus CallosotomySectioning the anterior two-thirds or complete corpus callosum to prevent interhemispheric propagation of generalized atonic drop attacks in Lennox-Gastaut syndrome.
Minimally InvasiveMR-Guided Laser Interstitial Thermal Therapy (MR-gLITT)Stereotactically guided laser fiber coagulates deep epileptogenic targets (e.g., hypothalamic hamartoma, periventricular nodular heterotopia) under real-time MR thermometry.
Minimally InvasiveRadiofrequency Thermocoagulation (RF-TC)Thermal lesioning applied directly through pre-existing SEEG depth electrodes.

Neuromodulation: Vagus Nerve Stimulation (VNS)

Neuromodulation is indicated when resective surgery is contraindicated (e.g., multifocal onset, unresectable eloquent cortex, or failed resective surgery).

Mechanism And Implantation

  • The pulse generator is implanted subcutaneously in the left infraclavicular chest wall.
  • Bipolar helical leads are coiled around the left vagus nerve (Cranial Nerve X) in the carotid sheath.
  • The left vagus is chosen because the right vagus nerve carries heavy parasympathetic innervation to the cardiac sinoatrial (SA) node, posing a risk of severe bradyarrhythmias.
  • Afferent vagal fibers project retrograde to the nucleus tractus solitarius (NTS), locus coeruleus, and dorsal raphe nuclei, modulating thalamocortical networks and releasing norepinephrine and serotonin to suppress cortical hyperexcitability.

Clinical Indications And Efficacy

  • Adjunctive therapy for drug-resistant focal or generalized epilepsy, particularly Lennox-Gastaut syndrome.
  • Efficacy increases over time: $\ge 50\%$ seizure reduction is achieved in 50% to 60% of pediatric patients by 1 to 2 years, with significant reductions in post-ictal recovery time and emergency room visits.
  • AutoStim Technology: Modern VNS models continuously track heart rate; detecting rapid ictal tachycardia triggers an immediate automated high-output electrical pulse to abort an evolving seizure.
  • Handheld Magnet Wand: Family members or patients can swipe a handheld magnet over the generator at seizure onset to deliver an extra stimulation cycle and terminate or shorten the event.

Adverse Effects And Precautions

  • Stimulation-associated side effects: Transient hoarseness, voice alteration, tickling cough, and throat paresthesia during the active stimulation cycle.
  • Precaution during induction of anesthesia: Generator should be turned off or magnet placed over it to prevent accidental intraoperative stimulation.
  • MRI safety: Modern VNS systems are 1.5T and 3.0T MRI-conditional provided specific manufacturer RF limits are observed.

Prognosis (Engel Outcome Scale)

  • Engel Class I: Seizure-free or non-disabling simple partial seizures only.
  • Engel Class II: Rare disabling seizures ("almost seizure-free").
  • Engel Class III: Worthwhile improvement ($\ge 75\%$ seizure reduction).
  • Engel Class IV: No worthwhile improvement.
  • Well-selected pediatric resective surgeries achieve Engel Class I outcomes in 65% to 80% of cases, enabling tapering of ASMs and cognitive improvement due to neuroplasticity.